Evidence map›Paper›PMID 37569841›Full record

ArticleInternational journal of molecular sciences2023

BRAF, TERT and HLA-G Status in the Papillary Thyroid Carcinoma: A Clinicopathological Association Study.

Bruna C Bertol, Juliana D Massaro, Guilherme Debortoli, André L P Santos, Jéssica N G de Araújo, Tatiana M V Giorgenon, Matheus Costa E Silva, Nathalie L de Figueiredo-Feitosa, Cristhianna V A Collares, Luiz Carlos C de Freitas and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. MicroRNA Profiling in Papillary Thyroid Cancer.International journal of molecular sciences · 2024
    Article
  6. Review
  7. Review
  8. Article
  9. International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Bruna C BertolPostgraduate Program of Basic and Applied Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.ORCID 0000-0002-9301-449X
Juliana D MassaroDivision of Clinical Immunology, Department of Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
Guilherme DebortoliDepartment of Anthropology, University of Toronto, Mississauga, ON L5L 1C6, Canada.
André L P SantosDepartment of Medical Imaging, Hematology, and Clinical Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.ORCID 0000-0002-0900-0504
Jéssica N G de AraújoDepartment of Clinical Analysis and Toxicology, Federal University of Rio Grande do Norte, Natal 59012-570, Brazil.
Tatiana M V GiorgenonDivision of Endocrinology and Metabolism, Department of Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
Matheus Costa E SilvaDivision of Clinical Immunology, Department of Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
Nathalie L de Figueiredo-FeitosaDivision of Endocrinology and Metabolism, Department of Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
Cristhianna V A CollaresDivision of Clinical Immunology, Department of Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
Luiz Carlos C de FreitasDepartment of Ophthalmology, Otorhinolaryngology and Head and Neck Surgery, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.ORCID 0000-0002-2153-6512
Edson G SoaresDepartment of Pathology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
Luciano NederDepartment of Pathology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
Vivian N SilbigerDepartment of Clinical Analysis and Toxicology, Federal University of Rio Grande do Norte, Natal 59012-570, Brazil.ORCID 0000-0002-9252-0278
Rodrigo T CaladoDepartment of Medical Imaging, Hematology, and Clinical Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
Léa M Z MacielDivision of Endocrinology and Metabolism, Department of Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
Eduardo A DonadiPostgraduate Program of Basic and Applied Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
Universidade de São Paulo · BRUniversidade Federal do Rio Grande do Norte · BRUniversity Health Network · CAUniversity of Toronto · CA

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior #071/2013National Council for Scientific and Technological Development #457231/2013 and #302060/2019-7Programa Nacional de Cooperação Acadêmica (PRO-CAD) #88881-068436/2014-1São Paulo Research Foundation #2015/26556-0
6 · The paper itself

Abstract

As BRAF, TERT, HLA-G, and microRNAs have been individually associated with papillary thyroid carcinoma (PTC), we aimed to evaluate the individual and collaborative role of these markers in PTC in the same patient cohort. HLA-G and BRAF tumor expression was evaluated by immunohistochemistry. Using molecular methods, BRAF

Indexed as

Carcinoma, PapillaryMicroRNAsTelomeraseThyroid NeoplasmsHLA-G AntigensHumansMutationPromoter Regions, GeneticProto-Oncogene Proteins B-rafThyroid Cancer, PapillaryBRAF protein, humanHLA-G AntigensMicroRNAsProto-Oncogene Proteins B-rafTelomeraseTERT protein, humanbiomarkersmicroRNAspolymorphismsthyroid cancer

Identifiers

PMID37569841
PMCPMC10419559
OpenAlexW4385607509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.